Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for upper-limb manual ability in children with congenital spastic hemiplegia
2009-015620-29Phase 4Completed
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in Congenital Hemiplegia. Primary endpoint: Upper-limb and bimanual activity outcome at 9 months after injection. Started Feb 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Congenital Hemiplegia
Beyond the preview
Go deeper on 2009-015620-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015620-29.